Information  X 
Enter a valid email address

Anglo African O&G (AAOG)


Tuesday 29 September, 2020

Anglo African O&G

Issue of Equity

RNS Number : 3604A
Anglo African Oil & Gas PLC
29 September 2020


Anglo African Oil & Gas plc

("AAOG" or "the Company")

Issue of Equity


The Company announces that it has today issued 10,566,356 new ordinary shares of 0.1p each at a price of 0.2366p each in respect of the conversion by Riverfort Global Opportunities PCC Limited ("Riverfort") of £25,000 principal of the convertible loan note entered into between the Company and Riverfort on 10 June 2020.  Application has been made for the admission of the new ordinary shares to trading on AIM ("Admission") and dealings are expected to commence on 2 October 2020. 

On Admission, the Company will have 499,434,220 Ordinary Shares in issue and there are no shares held in treasury. Therefore, the Company's total number of Ordinary Shares with voting rights is 499,434,220.  The figure of 499,434,220 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.




Anglo African Oil & Gas plc

[email protected]

Sarah Cope, Non-Executive Chair




finnCap Ltd (Nominated Adviser)

Tel: +44 20 7220 0500

Christopher Raggett, Giles Rolls, Teddy Whiley (Corporate Finance)





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t